# Institut Marquès — Full Technical Profile & Clinical Knowledge Base **Date Generated**: 2026-07-06 **Domain**: `https://www.institutomarques.com` > [!NOTE] > This document concatenates all primary clinical profiles, service descriptions, doctor roles, and trust indicators for consumption by AI tools. ## 🏛️ Clinical Profile & Foundations # Institut Marquès_SEO_Superbrief - Clinical Foundation SEO SUPERBRIEF 2026 Detailed Information Gathering for Local SEO and AI Content Optimization In the era of dynamic search evolution, driven by generative Artificial Intelligence (AI) and features like Google AI Overviews, it is crucial that we personalize and optimize our online content as much as possible for local search. This brief serves as a comprehensive tool for collecting specific and detailed information about each FutureLife clinic. The goal is to: Maximize Local SEO: Improve the visibility of clinics in local search results (e.g., 'IVF Prague', 'assisted reproduction center Brno') and within Google Business Profile. Strengthen E‑E‑A‑T (Experience, Expertise, Authoritativeness, Trustworthiness): Demonstrate to Google, AI, and users the unique expertise, experience, authority, and trustworthiness of each clinic based on real, verifiable data. Personalize and Optimize Content for AI: Adapt and generate website content to be tailored to the specifics, advantages, and local needs of each individual clinic. Increase the chance of our content being included in AI‑generated overviews and responses as a trusted source. Obtain Data for Structured Data (Schema.org): Semantically enrich content for better understanding by search engines and AI. Please fill out this brief as thoroughly as possible for each specific clinic for which you are responsible. The more detailed and accurate the information, the more effectively we can optimize online presence and attract relevant patients. # Part 1: Basic Information and Clinic Profile **• Full Official Name of the Clinic:** - Institut Marquès **• Exact Address of the Clinic (including postal code):** - **Institut Marquès Barcelona:** Av. Diagonal 662-664, 08034, Barcelona - **Institut Marquès Sabadell:** Avocat Cirera, 18, 08201, Sabadell - **Institut Marquès Roma:** Via del Giordano, 34, 00144, Roma - **Institut Marquès Milano Via Pallavicino:** Via Pallavicino, 21, 20145, Milano - **Institut Marquès Milano Santa Croce:** [Via Santa Croce, 8, 20122 Milano MI, Italia](https://www.google.com/maps/place/data=!4m2!3m1!1s0x4786c58cffcea57b:0xebaf829eb6047198?sa=X&ved=1t:8290&ictx=111) **• Phone Number for Patient Contact:** - Institut Marquès Barcelona: +34932906882 - Institut Marquès Sabadell: +34937256726 - Institut Marquès Roma: +390287368765 - Institut Marquès Milano: +390697628734 **• Email for Patient Contact:** - Spanish Patient: infonacional@institutomarques.com - International Patient: info@institutomarques.com **• Official Website URL of the Clinic:** - Institut Marquès: [https://institutomarques.com](https://institutomarques.com) - Área Joven - Sperm Donor: [https://donantesdesemen.com](https://donantesdesemen.com) - Área Joven - Egg Donor: [https://donantesdeovulos.com](https://donantesdeovulos.com) - RainbowFertility: [https://rainbowfertilitybarcelona.com](https://rainbowfertilitybarcelona.com) **• Opening Hours (day by day):** - **Institut Marquès Barcelona, Sabadell, Roma, Milano Via Pallavicino** Monday: 09:00 – 18:00 - Tuesday: 09:00 – 18:00 - Wednesday: 09:00 – 18:00 - Thursday: 09:00 – 18:00 - Friday: 09:00 – 18:00 - **Institut Marquès Milano Santa Croce** Monday: 08:00 – 20:00 - Tuesday: 08:00 – 20:00 - Wednesday: 08:00 – 20:00 - Thursday: 08:00 – 20:00 - Friday: 08:00 – 20:00 **• URL of your Google Business Profile (if it exists):** - Área Joven - Egg Donor – Sperm Donor: [https://g.co/kgs/7g6PhuD](https://g.co/kgs/7g6PhuD) - Institut Marquès Sabadell: [https://g.co/kgs/GDzbCsX](https://g.co/kgs/GDzbCsX) - Institut Marquès Roma: [https://g.co/kgs/kKi8xBc](https://g.co/kgs/kKi8xBc) - Institut Marquès Milano Via Pallavicino: [https://g.co/kgs/xj3ghYL](https://g.co/kgs/xj3ghYL) - Institut Marquès Barcelona: [https://g.co/kgs/jYb17AU](https://g.co/kgs/jYb17AU) - Institut Marquès Milano Santa Croce: [https://share.google/LN21wJ16K1zljR8tb](https://share.google/LN21wJ16K1zljR8tb) **• Who is the main contact person for website/SEO communication on your side? (Name, Email, Phone)** - Sergio Peñuelas López - [sergio.penuelas@institutomarques.com](mailto:sergio.penuelas@institutomarques.com) / [sergio.penuelas@futurelifegroup.com](mailto:sergio.penuelas@futurelifegroup.com) - +34 687 84 54 10 **• What is the main mission, vision, and philosophy of your clinic? What motivates you?** - Excellence in our DNA Excellence is at the core of everything we do. It drives our work, defines our standards, and ensures that every step we take is focused on providing the highest quality of care for our patients. - Innovation and Research Pioneers in reproductive medicine, we explore uncharted territories – from studying the influence of music at life’s onset to the critical role of men in assisted reproduction and environmental preservation. - Personalised Patient Care We provide a tailored approach for each patient, offering a warm, human, and personal service. Our dedicated professionals stay by your side, from diagnosis to pregnancy follow-up. - Effective Communication Your voice matters. We ensure you are heard, informed, and feel special throughout your unique journey with us. - Accessibility and Convenience Our remote patient care and strategic scheduling minimise the need for travel, ensuring maximum convenience and ease. - Transparency and Trust Honesty and clarity guide our every step. From selecting the right treatment to witnessing the development of your embryos, we ensure a transparent and trust-filled journey. - Legacy and Expertise With over 100 years of history and four generations of gynaecologists, our family-founded clinic brings a rich legacy and profound expertise in assisted reproduction and gynaecology. - Comprehensive Male Factor Analysis Our specialised Andrology Unit enables deep assessment and treatment of male fertility, significantly enhancing the success rates of IVF cycles. - Advanced Technology and Safety State-of-the-art laboratories and rigorous safety protocols reflect our unwavering commitment to cutting-edge technology and patient safety. - Achieving the Best Success Rates Through interdisciplinary collaboration, continuous innovation, and a commitment to quality, we consistently achieve outstanding results, even in the most challenging cases. - In a Nutshell At Institut Marquès, science, care, and innovation converge to fulfil the dream of parenthood. **• Do you have any specific target group that specifically comes to you and is generally known? (e.g., same‑sex couples, single women, patients with one testicle, specific ethnic groups, international patients – please specify their language/nationality, etc.)** - Main Patients: (considering ICs from 2024) **IVF**: Most common ages are between 32 and 47. The most common age is 40. Spain: The most common ages are between 32 and 43. The most common age is 38. - Straight couple: 73% - LGTBI: 11% - Single: 16% - Italy: The most common ages are between 32 and 46. The most common age is 40. - Straight couple: 71% of italian patients. - LGTBI: 15% of italian patients. - Single: 14% of italian patients. - France: The most common ages are between 35 to 47. The most common age is 40. - Straight couple: 71% of french patients. - LGTBI: 7% of french patients. - Single: 21% of french patients. - **Egg Freezing:** Spain: The most common ages are between 33 and 40. The most common age is 35. - Straight couple: 11% of spanish patients. - LGTBI: 2% of spanish patients. - Single: 88% of spanish patients. - Italy: The most common ages are between 34 and 40. The most common age is 36. - Straight couple: 6% of spanish patients. - LGTBI: 1% of spanish patients. - Single: 93% of spanish patients. - France: The most common ages are between 33 and 39. The most common age is 36. - Straight couple: 6% of french patients. - LGTBI: 3% of french patients. - Single: 91% of french patients. - **Donors:** Most common age between 19 and 29. The most common age is 24. - Spain. **• A short description of the clinic (1–2 sentences) that distinguishes it and captures its identity OR main motto/claim of the clinic:** - Institut Marquès is an internationally recognised fertility clinic, treating patients from 52 countries and reporting its results transparently to the Spanish Fertility Society (SEF). Our focus is on safety, transparency, and success, ensuring patients achieve their goal: a healthy baby at home. ** Social Media Profiles:(Facebook, Instagram, LinkedIn, YouTube)** - https://www.facebook.com/institutomarques/ - https://www.instagram.com/institut_marques_clinic/ - https://es.linkedin.com/company/institut-marqu-s - https://www.youtube.com/user/institutomarques/  **Professional Directories & Portals:****(Doctolib, ZnamyLekar, Estheticon, Yelp, Bing Places, etc.)** - **Top Doctors:** https://www.topdoctors.es/centro/institut-marques/ - **WhatClinic:** https://www.whatclinic.com/fertility/spain/barcelona/institut-marques - **SeenFertility:** https://seenfertility.com/search-results-page/clinic/institut-marques-barcelona/ - **WorldClinics: **https://www.worldclinics.net/en/clinic/institut-marques-barcelona - **Google My Business** - **Doctoralia: **https://www.doctoralia.es/clinicas/institut-marques-2 - **Bing places:** https://www.bing.com/maps/search?mkt=es-ES&ss=id.ypid%3AYN6306x16348335705398249035&cp=41.389271%7E2.128800&lvl=16&style=r - **Creating Family Magic:** https://creatingfamilymagic.com/listing/institut-marques/ - **Mundo Fertilidad:** https://www.mundofertilidad.com/centro-institut-marques_Barcelona_1010.html - **Fiv.fr: **https://www.fiv.fr/clinique-don-ovocytes-institut-marques-barcelone/ - **Les Fivettes Espagnoles: **https://lesfivettesespagnoles.com/clinique/institut-marques/ - **EggDonation Friends:** https://www.eggdonationfriends.com/clinics/institut-marques/ - **Fertility Clinics Abroad: **https://www.fertilityclinicsabroad.com/clinics/institut-marques/ - **Fertility Road: **https://fertilityroad.com/clinics/institut-marques/ - **Where IVF**: https://www.whereivf.com/clinics/institut-marques/ - **Eizellspendefreunde: **https://www.eizellspendefreunde.de/ - **Kinderwunsch im Ausland: **https://www.kinderwunsch-im-ausland.de/kliniken/institut-marques/ - **Ovodonazione All’estero: **https://www.ovodonazioneallestero.it/cliniche/institut-marques/ - **Cliniche FIV All’estero: **https://www.clinichefivallestero.it/cliniche/institut-marques/ - **Cliniche Fecondazione Eterologa: ** - **Les Amis du Don D’ovocytes:** https://www.lesamisdudondovocytes.fr/cliniques/institut-marques/ - **Cliniques de Fertilité a L’étranger: **https://www.cliniquesdefertilitealetranger.fr/cliniques/institut-marques/ - **Strada per un sogno: **https://www.stradaperunsogno.org/agevolazioni/institut-marques/ - **ART Fertilité: **https://art-fertilite.com/pma-etranger/nos-cliniques-partenaires/clinique-institut-marques/  **Official Register Entries:**(Links to the clinic’s profiles in national medical/regulatory registers such as SÚKL / HFEA / NCZI / SEF) - [https://cnrha.sanidad.gob.es/detalleCentro.do?ccn=0908002887](https://cnrha.sanidad.gob.es/detalleCentro.do?ccn=0908002887) - [https://cnrha.sanidad.gob.es/listadoCentrosCcaa.do?cod_ccaa=09](https://cnrha.sanidad.gob.es/listadoCentrosCcaa.do?cod_ccaa=09) # Part 2: Services and Specializations (Your Area of Excellence) **• A complete list of all services and treatment methods you offer in reproductive medicine. (e.g., IVF, ICSI, IUI, PGT, egg donation, sperm donation, egg/sperm/embryo freezing, infertility diagnostics – which specific ones? immunology, urology, andrology, gynecology genetics, psychological support, etc.)** | **Treatment** | **Detail** | | Egg Thawing (Nacional) | Oocyte devitrification + IVF | | Egg Thawing (Internacional) | Oocyte devitrification + IVF | | Embryo Donation | Embryo Donation | | Embryo Donation (Internacional) | Embryo Donation | | Embryo Donation VIP (Nacional) | Embryo Donation | | Embryo Donation VIP (Internacional) | Embryo Donation | | Fertility Preservation | Oocyte cryopreservation | | Frozen Embryo Transfer (Nacional) | FET | | Frozen Embryo Transfer (Internacional) | FET | | Intrauterine Insemination (Nacional) | Sperm donor insemination | | Intrauterine Insemination (Internacional) | Sperm donor insemination | | Intrauterine Insemination (Nacional) | Conjugal insemination | | Intrauterine Insemination (Internacional) | Conjugal insemination | | In-Vitro Fertilisation - Donor Eggs | ED (4 eggs) (Donor medication not included) | | In-Vitro Fertilisation - Donor Eggs | ED (6 eggs) + jft (Donor medication not included) | | In-Vitro Fertilisation - Donor Eggs VIP | ED (6 eggs) (Donor medication not included) | | In-Vitro Fertilisation - Donor Eggs | IVF DO WITHOUT TRANSFER | | In-Vitro Fertilisation - Donor Eggs (Bcn price) | DOD | | In-Vitro Fertilisation - Own Eggs | IVF | | In-Vitro Fertilisation - Own Eggs VIP | IVF - VIP | | In-Vitro Fertilisation - Own Eggs | Spontaneous IVF | | IVF w/o Transfer | IVF without transfer with freezing | | IVF w/o Transfer | IVF Accumulation | | ROPA | ROPA | | ROPA (VIP) | ROPA | | ROPA w/o | ROPA without transfer with freezing | | ROPA w/o | ROPA Accumulation | | REFUNDING PROGRAM | | | IVF (Nacional) | IVF | | IVF (Internacional) | IVF | | Egg Donation | ED | | Embryo Donation (Nacional) | Embryo Donation | | Embryo Donation (Internacional) | Embryo Donation | | DOD Transfer in Rome | DOD | | PACKS | | | TANDEM | IVF + Ovodonation pack | | Fertility Preservation | Oocyte cryopreservation 2 cycles + 3 years storage | | Intrauterine Insemination with donor | Sperm donor insemination - 3 cycles | | Intrauterine Insemination with donor (internacional) | Sperm donor insemination - 3 cycles | | Intrauterine Insemination | Conjugal insemination - 3 cycles | | Intrauterine Insemination (internacional) | Conjugal insemination - 3 cycles | | OVODONATION GUARANTEES | | | Guarantee 1 bl | Ovodonation Guarantee 1b | | Guarantee 2 bl | Ovodonation Guarantee 2b | | DOD Guarantee 2bl | DODT Guarantee 2b | | Guarantee 1 euploid blastocyst | Including blasto+embry+medic donor | - **A complete list of lab methods you offer in the field of reproductive medicine** | **Technics** | **Detail** | | EMBRY | Embryoscope | | BLASTO | Blastocyst | | FERTILE | Chip Fertile | | SINGLE AND DOUBLE STRANDED DNA FRAGMENTATION | | | FISH | | | SEMEN ANALYSIS+FREEZING | | | SEMEN ANALYSIS | Seminogram | | OUTPATIENT SEMEN ANALYSIS | External patient seminogram | | IAD SEMEN BANK | Sperm Bank (Insemination) | | SEMEN BANK | Sperm Bank (IVF) | | SEMEN BANK | Sperm Bank (Special-phenotype) | | SEMEN FREEZING | Sperm Freezing | | EMBRYO FREEZING | Embryofreezing | | Frozen maintenance | Embryo storage | | Frozen maintenance | Sperm storage | | Frozen maintenance | Egg storage | | Otros | Assisted Hatching | | Otros | Polaraid | | PGT | PGT Express (d3) [price to analyse 6 to 8 embryos] | | PGT | PGT (d5) [price to analyse 6 to 8 embryos] | | Embryo biopsy for PGT | | | PGT study | Unit price [from 1 to 5 embryos]. | | Bioarray | Bioarray | | Bioarray patient + patient ó patient + donor | Bioarray | | Donor matching | Bioarray | | Bioarray donor + donor | no cost | | Acupuncture (double session) | Acupuncture | | External Acupunture | Acupuncture | | Acupuncture (single session) | Acupuncture | | IVF | Transfer | | IVF | Desvitri | | IVF | Donor medication EGG4 | | IVF | Donor medication | • A complete list of laboratory methods you offer in the field of reproductive medicine | **Technics** | **Detail** | | EMBRY | Embryoscope | | BLASTO | Blastocyst | | FERTILE | Chip Fertile | | SINGLE AND DOUBLE STRANDED DNA FRAGMENTATION | | | FISH | | | SEMEN ANALYSIS+FREEZING | | | SEMEN ANALYSIS | Seminogram | | OUTPATIENT SEMEN ANALYSIS | External patient seminogram | | IAD SEMEN BANK | Sperm Bank (Insemination) | | SEMEN BANK | Sperm Bank (IVF) | | SEMEN BANK | Sperm Bank (Special-phenotype) | | SEMEN FREEZING | Sperm Freezing | | EMBRYO FREEZING | Embryofreezing | | Frozen maintenance | Embryo storage | | Frozen maintenance | Sperm storage | | Frozen maintenance | Egg storage | | Otros | Assisted Hatching | | Otros | Polaraid | | PGT | PGT Express (d3) [price to analyse 6 to 8 embryos] | | PGT | PGT (d5) [price to analyse 6 to 8 embryos] | | Embryo biopsy for PGT | | | PGT study | Unit price [from 1 to 5 embryos]. | | Bioarray | Bioarray | | Bioarray patient + patient ó patient + donor | Bioarray | | Donor matching | Bioarray | | Bioarray donor + donor | no cost | | Acupuncture (double session) | Acupuncture | | External Acupunture | Acupuncture | | Acupuncture (single session) | Acupuncture | | IVF | Transfer | | IVF | Desvitri | | IVF | Donor medication EGG4 | | IVF | Donor medication | **• Does the range of services change depending on the market in which you promote your services? Describe if necessary.** - Yes, check service and treatment methods. **• Do you have any specific, unique, or above‑standard treatment methods/protocols that competitors do not offer or not to such an extent in a specific market? Please describe them in detail. (e.g., time‑lapse embryo monitoring, microfluidics, specific laboratory protocols, innovative treatment approaches).** - Blastocyst culture system - Time-lapse incubators - Embryomobile - Embryoglue - Fertile Chip (Sperm selection with microfluidic chips) - ICSI - PGT - Testicular Biopsy - Testicular Sperm Aspiration (TESA) - Testicular Sperm Extraction (TESE) **• What are you the biggest experts in? Which services or types of cases are your strongest suit/specialization? Why? (Please be as specific as possible – e.g., 'We are the leading experts in PGT‑A in the region due to our in‑house genetic laboratory and team.'; ‘Proven highest success rate’)** - We are specialists in highly complex cases. **• Do you use any specific, modern, or unique technologies/equipment in the laboratory or during examinations? Describe them and their benefits for patients and treatment success. (e.g., specific incubators, AI systems for embryo evaluation, advanced diagnostic devices).** - **Embryomobile**: Time-lapse incubators allow biologists to continuously evaluate embryonic development. Unlike conventional incubators, which only allow for a single evaluation per day, this allows us to detect abnormalities in the morphokinetics of embryonic development and optimize embryo selection to choose the embryo with the highest probability of success in each transfer. - **Study of meiosis** in semen without the need for biopsy - Possibility of performing **follicular puncture via vaginal, abdominal, or combined routes for myomatosis or extrapelvic ovaries** - **NIPT in miscarriages** for fetal karyotype study without the need for chorionic villus sampling (only maternal blood analysis) - **Availability of two 100% independent laboratories**, in case one needs to be reviewed or stops working due to incidents - **Use of lasers during embryonic biopsy: **During embryo biopsy at the blastocyst stage, we need to separate 4-8 cells from the trophectoderm (future placental tissue) to perform genetic analysis (PGT). The use of lasers during this procedure allows us to minimize cell damage during blastocyst biopsy, maximizing success rates. - **“Issolate**” workstations: Throughout the IVF treatment, embryologists must maintain stable working conditions that simulate the uterine environment. To do this, we must control the temperature at 37ºC, CO2 at 6%, and O2 at 5%. During the manipulation of oocytes and embryos, this is vitally important, as deviations from these conditions can seriously affect success rates. Until the development of these closed workstations, embryologists had to work in open stations that did not allow for the control of gas concentrations, forcing them to work quickly to avoid damage to the biological material. That is why we have incorporated closed workstations at the Institut Marques Laboratory. These new-generation workstations allow embryologists to work in optimal conditions while handling biological material, minimizing stress on reproductive cells. - **VOC sensors in IVF laboratories: **Maintaining optimal quality in the IVF laboratory is essential for good treatment results. There are contaminants, such as VOCs, that affect embryo development and reduce pregnancy rates. We use air quality sensors that allow us to detect the presence of these contaminants and take corrective measures before they can affect clinical results. **• What are your success rates for key procedures (e.g., IVF)? (Please state the data source and calculation methodology if relevant for public communication and verifiable. How do you communicate success rates to patients – internally/externally?)** **Success rates endorsed by the Spanish Fertility Society (SEF).** **EGG DONATION** *Patients who can freeze embryos after the transfer 85,8%* | | Institut MarquèsPartner’s sperm | Institut MarquèsDonor sperm | | Pregnancy / cycle | 87,2% | 91,5% | | Clínical pregnancy / cycle | 80,8% | 87,4% | | Live birth rate / cycle | 77,8% | 84,0% | | Twin pregnancies | 3,2% | 3,2% | | Average of frozen embryos | 2,7 | 3,0 | | Average of transferred embryos | 1,1 | 1,1 | **EGG DONATIONNumber of eggs (Institut Marquès)** | | Average of good quality blastocysts | Pregnancy rate by transfer | Pregnancy rate by cycle | | Egg 4 | 2,1 | 61,5% | 85% | | Egg 6-7 | 3,1 | 65,2% | 91% | | Egg +8 | 3,2 | 65% | 90% | *Pregnancy rates mean pregnancies achieved with embryos coming from an egg collection.* This includes the transfer of fresh embryos as well as the possible transfers of frozen embryos. **IVF WITH OWN EGGS** | | IM<35Partner’s sperm | IM<35Sperm bank | IM 35-39Partner’s sperm | IM 35-39Sperm bank | IM≥40Partner’s sperm | IM≥40Sperm bank | | Pregnancy / cycle | 82,6% | 91,4% | 68,1% | 80,3% | 36,1% | 31,6% | | Clínical pregnancy / cycle | 76,6% | 84,7% | 62,3% | 73,7% | 27,7% | 26,6% | | Live birth rate / cycle | 74,2% | 77,1% | 57,1% | 68,8% | 16,6% | 26,6% | | Twin pregnancies | 4,0% | 4,2% | 4,1% | 4,0% | 0% | 0% | | Average of frozen embryos | 4,0 | 3,6 | 3,2 | 3,5 | 2,3 | 2,4 | | Average of transferred embryos | 1,2 | 1,1 | 1,2 | 1,1 | 1,3 | 1,2 | *Cicles with PGT and embryo accumulation included* **CRIOTRANSFERS** | | Institut Marquès | | Pregnancy / transfer | 56,5% | | Clinical pregnancy | 47,7% | | Live birth rate | 37,1% | | Twin pregnancies | 2,9% | **EMBRYO DONATION** | | Institut Marquès | | Pregnancy / transfer | 57,1% | | Clinical pregnancy | 48,2% | | Live birth rate | 37.9% | | Twin pregnancies | 2,4% | **PGT** | | Institut Marquès | | Pregnancy / cycle | 90,7% | | Clínical pregnancy / cycle | 80,4% | | Live birth rate / cycle | 78,7% | | Twin pregnancies | 5,0% | **ONCOLOGICAL PATIENTS** | | Institut Marquès | | Pregnancy / cycle | 82% | *Cicles with PGT and embryo accumulation included* **ARTIFICIAL INSEMINATION (*)** | IUI Partner’s sperm | IM<35 | IM 35-39 | IM≥40 | | Pregnancy / cycle | 19% | 17,4% | 10% | | Clínical pregnancy / cycle | 16,5% | 15,4% | – | | Live birth rate / cycle | 14,0% | 15,4% | – | | IUI Donor sperm | IM<35 | IM 35-39 | IM≥40 | | Pregnancy / cycle | 28,5% | 22,0% | 25,0% | | Clínical pregnancy / cycle | 24,1% | 19,8% | 20,0% | | Live birth rate / cycle | 21,2% | 16,1% | 15,0% | *(*) Global results (they vary depending on the patient’s age)* ***Select 3–5 key services to be displayed as visual “Products” in the Google Business Profile. Each item can include a direct CTA leading to a conversion page.*** - **Product 1:** Name + Target URL (with UTM parameters) IVF - **Product 2:** Name + Target URL (with UTM parameters) Egg Donor IVF - **Product 3:** Name + Target URL (with UTM parameters) Egg Freezing - **Visual Requirement:** Confirm availability of a square, high‑quality photo for each product (no text overlay; must follow Google’s guidelines). IUI ## Part 2 – 2026 AI‑Structured Addendum (for AEO/GEO) • **For each key procedure, provide the following sub‑sections:** **• A) Process Breakdown: How long does the process take (days/weeks)? How many in‑clinic visits are required? Pre‑tests and preparation? Required documentation (informed consent, genetic tests, donor consents).** **• B) Legal & Regulatory Conditions: Is this procedure regulated in the given market (e.g., age limits, donor anonymity, eligibility rules for single women/LGBTQ+)? Which authority oversees it (SÚKL, HFEA, NCZI, SEF, etc.)? Mandatory reporting (national registries)?** **• C) Machine‑Readable Facts: Procedure type; start–end duration in days; success rate (with methodology and cohort definition); top 3 verifiable advantages.** Egg Freezing Process: IVF Process: Ropa Method Process: EGG DONOR IVF: # Part 3: Pricing **• Do you have an official price list available for patients?** - Yes **• Do you offer any special treatment packages or price bundles? (Discounted cycles, refund guarantees, multi‑cycle packages, all‑inclusive options for international patients, etc.)** - Yes **• Please describe them:** - **IM BABYBORN 100% GUARANTEE** We offer you the opportunity to get reimbursed 100% of the amount of your treatment if, after three cycles, we have not achieved an evolving pregnancy. **• Do you offer price guarantees, refund programs, or specific financial advantages for patients?** - Yes **• Do you receive frequent patient questions about prices?** - Yes **• Which treatments or services do patients ask about the most regarding cost?** - Almost all treatments. Refunding - IVF - Guarantee - Egg Freezing - IVF Tandem - Mini IVF - Maintenance - PGT - Sperm Freezing **• Are there common misunderstandings or areas where price communication could be improved?** - Refunding - Access Fertility # Part 4: Team and Expertise (E‑E‑A‑T Signals) à check CV/BIOS page **Who are the key doctors and embryologists at your clinic? Do you have other specialists on your team (e.g., nurses, psychologists, geneticists, immunologists, andrologists)? Please indicate notable roles (e.g., boards, media presence).** For each key doctor/embryologist, please provide: • Full Name and Titles (e.g., MUDr. Jan Novák, Ph.D.) • Main Specialization/Expertise (e.g., reproductive immunology, male infertility, PGT) • URL to bio/profile on the clinic's website (if it exists) • Significant publications/research contributed to (with links, if online and relevant) • Memberships in professional societies, any awards/certifications (with years obtained, if possible) • What makes your team unique? What is the team's approach to patients (e.g., personal, empathetic, scientific, holistic)? • Do any team members have specific international experience or recognition? (e.g., work in international clinics, presentations at international conferences). *In which languages is this specialist able to conduct a full medical consultation without an interpreter?* - **Languages:** (e.g., English, German, French, Czech, Spanish…) ## Part 4 – 2026 Trust Extensions (Mandatory for AI Verification) **• Professional Registration Number (ID): e.g., ČLK (CZ), GMC (UK), SEF (ES) — include authority + number.** | Country | Required Authority | Required ID | Applies To | Regulatory Basis | | Spain | Colegio Oficial de Médicos (provincial) | Número de colegiado | Physicians, IVF specialists | Guía RHA 2024; Ley 14/2006; RD‑ley 9/2014 | | | FFEBR (embryologists) | Inclusion in authorised centre staffing | Embryologists | Guía RHA 2024 (RE.33–RE.34) | | Italy | OMCeO (provincial Medical Order) | Numero di iscrizione all’albo | Physicians | Legge 40/2004; FNOMCeO + SOHO | | | Ordine dei Biologi (where applicable) | Registration number | Embryologists / Lab professionals | Legge 40/2004; SOHO | **• Research Footprint Links: ORCID ID, PubMed profile URL, Scopus/Web of Science ID (if available), and DOIs of key publications.** - We don’t have this / I don’t know where to find it # Part 5: The Patient and Their Experience **• What are the most common questions or concerns that patients approach you with? (Before treatment, during treatment, after treatment – e.g., 'How much does IVF cost?', 'What is the waiting time for a consultation?', 'Does egg retrieval hurt?', 'What to do after embryo transfer?').** - How much does the treatment cost? - What is the process like? - What does the price of this treatment include? - How much does it cost to maintain my eggs? - Will I be able to live a normal life? - Do you treat international patients? - Is there a waiting list for the first visit? - How long will I have to wait to start treatment? - Do you collaborate with any clinics in my country to carry out the preliminary medical examination? (for international patients) - How long do I have to stay there? (for international patients) When do I have to travel? **• Do you offer any form of psychological support or counseling for patients? How is this service integrated into the treatment?** - Yes, but only for local patients. In addition, this service is paid separately. **• Do you offer extra services for patients? (e.g., help with accommodation, coordinator for international patients, interpreting, nutritional counseling, physiotherapy, etc.) Please describe them.** - **Accommodation**: we work with nearby hotels and offer our patients a discount. - **Acupuncture**: we offer an in-house acupuncture service. Patients must pay for this treatment. - **Psychologist**: In-house psychology service for our patients. The first informational visit is free of charge. If you would like additional visits, you will be required to pay for them. We collaborate with external psychologists if our patients require more ongoing treatment. - **Massage** - We do not require interpreters because we have an international team that can assist patients in Spanish, English, German, French, Italian, and Catalan. **• Do you have anonymized testimonials or success stories available? (Provide URLs if online or describe how you obtain them.)** - [**https://www.youtube.com/watch?v=pX4NPir8ujE**](https://www.youtube.com/watch?v=pX4NPir8ujE) - [**https://www.youtube.com/watch?v=NgHaIp6xkPA**](https://www.youtube.com/watch?v=NgHaIp6xkPA) - [**https://www.youtube.com/watch?v=MbINwdh0aag**](https://www.youtube.com/watch?v=MbINwdh0aag) **• What do you think patients appreciate most about your clinic?** - The treatment they receive, the facilities, the fact that we have an international department, the clinic's experience and history, that we specialize in complex cases, the laboratories, our collaboration with Treedom, and our commitment to the environment. # Part 6: Uniqueness and Differentiation from Competitors (USPs) **• What, in your opinion, is the MOST IMPORTANT thing that distinguishes your clinic from others? Please be as specific as possible and list 3–5 main points.** - More than 100 years creating families - International multilingual approach - Premium clinic **• Why should a patient choose your clinic over the competition? What are your main competitive advantages? Local vs. Foreign market** - Success rates - Technology - Our experience - Premium clinic - LGBTQ+ **• What is the atmosphere or 'spirit' of your clinic? (e.g., family‑like, highly scientific, very personal, modern and high‑tech, calm and discreet?) Please describe how this is manifested.** - High-tech premium clinic - The clinic is a high-tech premium. All our facilities and the treatment our patients receive position us as a premium clinic within the market. In addition, our laboratory has cutting-edge technology that positions us as high-tech. **• Are there any stories or traditions associated with your clinic that are worth mentioning and that could resonate with patients? (e.g., long‑standing history, founding story, special events.)** - **100 years at the forefront of gynecology and obstetrics** The name Institut Marquès corresponds to the surname of a family whose members have been the link of union and continuity. Its founder was [**Dr. Vicens Marquès i Bertran**](https://institutomarques.com/el-dr-vicens-marques-pionero-de-la-ginecologia/) (Barcelona, 1895-1977), who began practicing as a gynecologist in 1922, 100 years ago. Throughout this time, his vocation for gynecology has been passed down to four generations, from his son Dr. Leonardo Marquès Giraut to his grandson Dr. Leonardo Marquès Amorós and finally to his great-grandson, Dr. Borja Marquès López-Teijón. When the first of the Marquès doctors began his career as a gynecologist, most women gave birth at home and only patients with serious complications went to the hospital. In 1941, he founded and directed the ‘Sanatorio Maternal’, which, with 7,000 births and more than 2,000 gynecological procedures, became one of the most advanced hospitals in Spain at the time and greatly reduced maternal and fetal problems. Despite the great medical advance that this change represented, Dr. Vicens Marquès remained concerned about the suffering of his patients and, with the aim of alleviating it, promoted the use of analgesia. Another of his concerns was couples with fertility problems, as at that time little could be done to help them, which is why he became one of the founding members of the Spanish Fertility Society. In 1952, Dr. Vicens Marquès' eldest son, **Leonardo Marquès Giraut**, joined the clinic. In addition to working at the private Maternal Sanatorium, Dr. Leonardo Marquès was chief clinician at the Municipal Institute of Maternology and the Gynecology Services of the Hospital de Ntra. Sra. del Mar until 1969. He later created and directed the Sterility Service at the Red Cross Hospital in Barcelona until 1976. Following in his father's footsteps in his concern for sterility problems, he carried out important studies on the permeability of the fallopian tubes and received the ‘Fargas de la Academia de Ciencias Médicas de Barcelona’ award. In 1965, the Marquès doctors left their first clinic and, together with their colleagues, moved to the Quirón Clinic with the aim of improving patient care in a large medical center with all the specialists and surgical equipment at their disposal. In 1987, the third generation of gynecologists in the family joined the practice. The eldest of the brothers, **Dr. Leonardo Marquès Amorós** (Registration number: 18976), and **Dr. Marisa López-Teijón Peréz** (Registration number: 24007) began working at Institut Marquès with techniques that were innovative at the time, such as diagnostic and surgical hysteroscopy, while also promoting assisted reproduction techniques. In 1989, they set up the first in vitro fertilization laboratory in the operating rooms of the Quirón Clinic. Over the years, this laboratory has grown and incorporated the latest techniques, such as embryo freezing, intracytoplasmic injection (ICSI), sequential embryo culture, assisted hatching, etc. In the last decade, due to increased social demand, special attention has been paid to the egg and sperm donation program. In 2005, the **Preimplantation Genetic Diagnosis** (PGD) laboratory was created, positioning Institut Marquès as one of the pioneering reproduction centers in the genetic analysis of embryos, eggs, and sperm. That same year, the Institut Marquès [**Reproduction Service**](https://institutomarques.com/reproduccion-asistida/) moved to the [**CIMA Clinic**](http://www.cimaclinic.com/) and set up its offices in La Masía, an emblematic 17th-century building that forms part of Barcelona's artistic heritage and which, years ago, housed the Luis Vives general studies college. For its part, the [**Obstetrics and Gynecology Service**](https://institutomarques.com/ginecologia/) at Institut Marquès offers comprehensive gynecological care throughout the different stages of a woman's life. To this end, it has a medical team specializing in Gynecology Units for Children and Adolescents, Prenatal Diagnosis, Breast Pathology, Gynecological Oncology, and Endoscopy. In December 2017, Institut Marquès opened the doors of its current [**headquarters on Avenida Diagonal in Barcelona**](https://institutomarques.com/conocenos/instalaciones/institut-marques-barcelona/), where it offers a truly unique experience for future parents. In a clinic that breaks all the rules in terms of design, the latest technologies, care, and services, our patients feel at home in a warm and welcoming environment. With the addition of** Dr. Borja Marquès**, the fourth generation of gynecologists in the family is now part of the Institut Marquès team. **In 2022**, Institut Marquès partnered with [**FutureLife**](https://www.futurelife.eu/en/home/) for its international project. # Part 7: Location, Accessibility, and Local Reputation **• How accessible is the clinic for patients? (e.g., parking – where and at what cost, public transport availability – which lines and stops, proximity to major transport hubs, airport, train station).** - **Taxi:** From the airport: A trip from the airport to Institut Marquès usually takes between 20 and 40 minutes depending on several factors: the terminal from which the taxi departs, traffic conditions on the road, congestion when reaching the city center, and speed. - **Metro:** To get to Institut Marquès, get off at María Cristina station, line 3. From the airport: Take line 9 (L9 Sud Naranja) from “Aeropuerto T1” or “Aeropuerto T2” to the last stop, Zona Universitària, then change to line 3 (L3 verde) and get off at Maria Cristina station (exit: Diagonal – Capitán Arenas). Continue straight along Av. Diagonal for about 100 meters and you will find the clinic on your left. - **Bus:** To get to Institut Marquès, you can take bus lines H6, V3, 7, 59, 63, or 70. From the airport: Take bus 46 from Airport T1 or T2 to the last stop, “Plaza de España,” then change to Metro Line 3 (green) and get off at Plaza de España. Get off at Maria Cristina Station (Exit: Diagonal – Capità Arenas). Continue straight along Av. Diagonal for about 100 meters and you will find the clinic on your left. - **Tramway:** To get to Institut Marquès, you can take lines T1, T2, or T3. **• Are there other assisted reproduction clinics in the immediate vicinity? If so, how far away?** - **Ginemed:** 750m - **Fertilab:** 650m - **Grisreproducción:** 700m - **Gravida:** 210m - **NatuVitro:** 1,1km - **CRA Barcelona:** 1,3km - **Clínica Dexeus Mujer:** 700m - **Dona i Nen Fertility:** 1,7km **• What is your clinic's reputation in the local community or among experts (doctors, gynecologists) in the region? Does the clinic participate in local events, public awareness campaigns, or collaborate with local healthcare facilities?** - Institut Marquès has a solid reputation in the local community and among experts, especially in the field of assisted reproduction. The clinic stands out for its scientific approach, with a history of more than 100 years of excellence in gynecology and is recognized for its commitment to innovation and quality in treatments. In terms of its participation in events and collaboration with other health centers, Institut Marquès organizes and participates in conferences and scientific seminars, both nationally and internationally, to share knowledge and advance the field of assisted reproduction. In addition, it collaborates with other institutions and medical centers, which reinforces its presence in the community and its role as a leader in the sector # Part 8: Competition (For Market Understanding) **• Please list your main competitors locally and abroad if you are familiar with them.** - FertiLab - IVI - Eugin - Dexeus Fertility - Ginemed / Eva Clinics - Dona I Nen Fertility - BarcelonaIVF - CRA Barcelona **• What do you think your competitors' strengths are? (What do they do well?)** - FertiLab: Audited results, personalized service - IVI: Global infrastructure and high volume - Eugin: Europe's largest center - Dexeus Fertility: Pioneers with a solid history - Ginemed / Eva Clinics: Globally redundant competitors - Dona I Nen Fertility: Funding and multidisciplinary care - BarcelonaIVF: direct, specialized medical care, with a personal approach but using state-of-the-art technology - CRA Barcelona: Extensive catalog of treatments **• What do you think is your advantage over them? (What do you do better or differently?)** - FertiLab: **Real internationalization:** Institut Marquès has a greater international presence (Italy, Ireland, United Kingdom) and a solid base of foreign patients. - **More volume and accumulated clinical experience**, with >100 years of medical history. - **More complementary services**: fetal music therapy, in-house genetic studies, psychological support etc. - IVI **More personalized treatment**: IVI may be perceived as more formal and with less direct contact with doctors. - **More flexible and approachable in terms of protocols and emotional care**. - Eugin **Our own laboratory with recognized innovation** (such as the study of the endometrial microbiome, reproductive immunology, and music therapy). - **A more emotional and human approach** compared to a more industrialized structure such as Eugin. - **Donation program with greater control and individual traceability**. - Dexeus Fertility **Comprehensive approach to fertility and assisted reproduction**, not shared with other medical specialties. - **Extensive experience with international patients** and a truly multilingual structure. - **More flexibility in waiting times and communication**. - Ginemed / Eva Clinics **Greater stability and medical continuity**: Institut Marquès does not depend on a network with frequent staff turnover. - **A more solid scientific approach**, with our own research and publications in international journals. - **More demanding and personalized egg donation programs**. - Dona I Nen Fertility **Greater technology and resources** (laboratory, operating room, gamete bank, etc.). - **Greater medical experience** and the volume of cases treated. - **International presence** that Dona i Nen does not have. - BarcelonaIVF **More experience and a higher volume of international patients**. - **Own lines of medical research**, especially in ovarian stimulation, blastocyst and genetics. - **Own reproductive immunology unit**, something unusual in other private clinics. - CRA Barcelona **Greater national and international recognition**. - **More modern and multidisciplinary infrastructure**. - **Greater investment in reproductive technology and embryo monitoring (Embryomobile, Geri, etc.)** # Part 9: Website and Online Presence (Technical and Content‑related) **• Is there any content on your existing website that you consider crucial for your clinic? (Please provide URLs).** - Press, news, history of Institut Marquès. **• Conversely, is there content that is outdated, inaccurate, or completely missing from the website and needs to be added? (e.g., a detailed description of PGT is missing, a page about psychological support, up‑to‑date team information).** - a page about psychological support - guarantees - financing ## Part 9 – 2026 Visual Entities & Video SEO Addendum **• Video Walkthrough: Is there an official video tour of the clinic (reception, consultation rooms, laboratories, patient rooms)? Provide URLs. Support 16:9, 9:16, and 1:1 formats for AI clip extraction.** - [https://www.youtube.com/watch?v=LxSOQj_NFGA](https://www.youtube.com/watch?v=LxSOQj_NFGA) **• Visual Metadata (Real Photos Only): Provide original, non‑stock photos with EXIF GPS coordinates, capture time, and device metadata to strengthen location authority.** - We have the photos in the server if needed. **• Object‑Level Entity Mapping: Identify equipment shown in photos/videos (incubators, microscopes, diagnostic devices) and link to manufacturer and certifications.** - We don’t have this info # Part 10: Institutional Authority & Research (Trust Anchors) **• Certifications & Accreditations: ISO standards (e.g., ISO 9001, ISO 15189), national regulators (SÚKL – CZ, HFEA – UK, NCZI – SK, SEF – ES), ESHRE certifications. Include year obtained and a verification URL.** - ISO 9001:2015 Valid until 10 June 2028 - UNE 179007:2013 Valid until 10 June 2028 **• Clinic‑Level Research & Publications: List key studies authored by the clinic. For each study: Title, Authors, DOI (mandatory), Journal URL, Year, Research area, and whether cited by professional societies.** **• Awards: List third‑party awards with the date and awarding institution. Include verification URLs.** # Part 11: Regional Compliance Filter **• Forbidden/Restricted Terms by Market: Define terms not allowed in each jurisdiction (e.g., DE – no superlatives or success guarantees; UK – HFEA restrictions on success claims; ES – donor communication limits; CZ – prohibition of false or absolute claims).** - Below is the consolidated list of terms and communication practices that are forbidden or restricted in Spain and Italy, with cross‑reference to the new EU SOHO Regulation requirements. **SPAIN – FORBIDDEN & RESTRICTED TERMS** (According to the *Guía de autorización e inspección RHA*, Ley 14/2006, RD‑ley 9/2014, RD 318/2016) **1. Advertising of gamete donation** **Forbidden:** - Any reference to economic incentives, payment, “salary”, “income”, or similar. - Mentioning the legal compensation amounts (45€ semen / 980€ oocytes). - Using testimonials, real or invented. - Any message that could induce or pressure a person to donate. - Publicity that is false, deceptive, exaggerated, or that creates unrealistic expectations. - Messages suggesting selection of donors by recipients (“choose your donor”). - Any reference that could identify a donor or “describe” donor phenotypes beyond the legal matching. **2. Success rates and outcomes** **Forbidden:** - Superlatives: “best”, “highest success rate”, “leaders”, etc. - Guarantees of success (“100% success”, “guaranteed pregnancy”). - Any statement not based on methodologically correct, age‑stratified, audited data. - Using global or non‑comparable statistics to imply superiority. **3. Communication with donors** **Forbidden:** - Identifying data of donors. - Any suggestion that donation is beneficial for health or “risk‑free”. - Any communication implying perks, privileges, or rewards. **4. Communication with patients** **Forbidden:** - Claims that trivialise the procedure (“quick”, “easy”, “safe and simple”). - Statements minimising risks of ovarian stimulation or anesthesia. - Absolute statements about genetic testing (“this eliminates all risks”). **5. Social media and digital channels** **Forbidden:** - Testimonials from influencers, celebrities, or patients. - Posts highlighting compensation, “rewards”, “benefits of donating”, etc. - Content that could indirectly reveal donor identities. - Recruitment through third parties or ex‑donors. **ITALY – FORBIDDEN & RESTRICTED TERMS** (According to *Legge 40/2004*, decrees of implementation, and regional rules + SOHO Regulation) **1. Advertising and donor recruitment** Italy has even stricter prohibitions than Spain. **Forbidden:** - Any public advertisement that encourages gamete donation (*Legge 40 prohibits commercialization*). - Mention of economic compensation (Italy allows only reimbursement, not “compensation”). - Any message implying financial advantage. - Testimonials or commercial‑style advertising campaigns. - Messages implying donor selection or custom‑matching. **2. Success rates** **Forbidden:** - Guarantees or superlatives. - Comparisons suggesting superiority vs. other clinics. - Any data that is not transparent about the methodology. **3. Donor anonymity** Italy has *non‑anonymous* donation in certain aspects. Therefore: **Forbidden:** - Any message implying full anonymity. - Any suggestion that the clinic “selects the perfect donor”. **4. Medical risks** **Forbidden:** - Minimising medical risk. - Suggesting that ovarian stimulation has “no risks”. - Any message suggesting that IVF is “easy”, “risk‑free”, “simple”. **EU – SOHO Regulation (2024/2025) – Impact on Communication** The new SOHO Regulation applies across Europe and strengthens what is allowed in public communication.Key communication‑related prohibitions: **1. Prohibition of misleading statements** **Forbidden:** - Any statement that could mislead patients regarding quality, safety, or effectiveness. - Any non‑validated or non‑traceable success rates. - Any claim that is incompatible with the clinic’s validated internal data. **2. Safety, risk and accuracy** **Forbidden:** - Downplaying risks related to substances of human origin (gametes/embryos). - Suggesting that genetic testing or donor screening eliminates all risk. **3. Traceability & identification** **Forbidden:** - Any communication that conflicts with the mandatory traceability (SEC / EU code). - Any system that could create false expectations about donor choice or availability. **4. Transparency requirements** SOHO requires that communication be: - Accurate - Evidence‑based - Non‑promotional regarding safety/quality claims Therefore, any emotional, persuasive or overselling language becomes high‑risk. **Combined Prohibited Terms List (Spain + Italy + EU SOHO)** **Absolutely forbidden across both markets** - “Guaranteed pregnancy” / “100% success” - “Highest success rates” - “Best clinic in Europe” - “Safe and risk‑free treatment” - “Payment for donation” / “Earn money donating” - “Choose your donor” / “Select the best donor” - “Perfect donor match” - Testimonials, influencer endorsements - “Quick and easy fertility treatment” - Statements implying no medical risk - Emotional pressure (“Help couples have a baby now!”) - Statements contradicting anonymity laws (ES) or overstating anonymity (IT) - Any message implying that the clinic can “optimize”, “improve” or “fix” donor characteristics **• Approved Communication Variants (Whitelist): How to phrase outcomes, what sources/methodology must be cited (age distribution, cohort), and required disclaimers/limitations.** **A. APPROVED WAYS TO PHRASE OUTCOMES (Spain & Italy)** **1. When referring to success rates** Use only probabilistic, non‑absolute, methodologically transparent language. **Approved (Whitelist)** - “Clinical pregnancy rates vary depending on age and clinical history.” - “Our results correspond to the average of the last five years, stratified by age groups, as required by national regulation.” - “For women under 35, the clinical pregnancy rate in our centre during the indicated period was X%.” - “Results are presented following national registry criteria.” - “Outcomes depend on multiple factors, including ovarian reserve, semen quality, and embryo development.” - “These figures represent the cohort of cycles performed in our laboratory under validated protocols.” **Not permitted** - Superlatives (“best”, “leading”, “highest success”). - Guarantees (“we guarantee pregnancy”, “safe result”, “risk‑free”). - Non‑stratified global rates. (All prohibited under Spain’s RHA Guide requirements for veracity and clarity, and SOHO’s prohibition of misleading safety/quality claims.) **B. REQUIRED SOURCES & METHODOLOGY** Both Spain and Italy must follow **transparent, reproducible, evidence‑based methodology** when presenting outcomes. **1. Cohort definition** **Mandatory in Spain** (Guía RHA 2024): - Use **the last five years of centre‑specific data** or annual data if available. - Stratify by **age groups**: **<35 years** - **35–39 years** - **≥40 years** - Present **clinical pregnancy rate**, not biochemical rate. **Mandatory in Italy** (Legge 40 + regional decrees): - Use centre‑specific outcomes audited regionally. - Stratify by clinically relevant age brackets. - No comparative marketing (e.g., “better than X clinic”). **EU SOHO Regulation** requires: - Evidence‑based outcome statements, traceable to validated data sources. - Avoid any communication that misrepresents risk or overstates performance. **2. Approved Sources** **Spain** - **Registro SEF** (official Spanish Fertility Society data) - **SIRHA** (for traceability and cohort identification) - Internal audited laboratory outcomes (validated by quality controls required in the RHA Guide). **Italy** - Regional ART registries (Registro PMA regionally administered). - Ministry of Health annual reports. - Internal centre‑specific validated data. **EU** - Compliance with SOHO: traceable data, transparent description of cohorts, methodologies, and definitions. **C. APPROVED LANGUAGE (WHITELIST) FOR OUTCOMES & PROCEDURES** These formulations comply with both national laws and SOHO’s safety/accuracy requirements. **1. IVF/ICSI outcomes** - “Clinical pregnancy rates in IVF/ICSI depend primarily on patient age and the indications for treatment.” - “Based on our centre’s data from 20XX–20XX, the clinical pregnancy rate per transfer for women aged 35–39 was X%.” - “Outcomes are reported following the national registry methodology.” **2. Egg donation outcomes** - “Success rates in donor‑egg cycles reflect donor age (normally <35) and laboratory conditions.” - “Our data correspond exclusively to cycles performed in our centre using donors screened according to national and EU SOHO requirements.” **3. Fertility preservation** - “Success depends on age at cryopreservation, ovarian reserve, and the number of oocytes retrieved.” **4. Genetic testing (PGT)** - “Genetic testing reduces but does not eliminate the risk of genetic abnormalities.” - Required by the RHA Guide for PGT consent wording. **D. MANDATORY DISCLAIMERS & LIMITATIONS (Spain + Italy + EU)** **1. Risk disclaimer** Required by SOHO and national regulations: - “No technique can guarantee pregnancy.” - “Results depend on individual clinical factors and cannot be generalized to all patients.” **2. Data validity & methodology** - “Figures correspond to our centre’s activity under validated protocols, using the definitions required by national registries.” - “Results may vary based on cycle characteristics and treatment indications.” **3. Donor anonymity & legal constraints** **Spain** - “Donor selection is performed exclusively by the medical team in accordance with Spanish anonymity laws.” **Italy** - “Donor information is managed according to Italian law; no identifying information is disclosed.” **4. Genetic testing** - “PGT does not eliminate all genetic risks; residual risk remains.”Required in the RHA Guide under PGT communication rules. **5. Compensation** **Spain** - “Donation is voluntary and altruistic; compensation covers only inconvenience and expenses.”Required under RD 318/2016 and RHA inspection guide. **Italy** - “Reimbursement is limited to documented expenses; no compensation is permitted.” **E. WHITELIST SUMMARY (Ready-to-Use)** **Approved phrases** - “Clinical pregnancy rates vary by age and indication.” - “Data correspond to X–Y period and are centre‑specific.” - “Results follow national registry methodology.” - “No treatment can guarantee pregnancy.” - “Donor selection follows national legislation on anonymity and matching.” - “Genetic testing reduces but does not eliminate risk.” - “Success depends on multiple individual factors.” **Approved data presentation rules** - Age‑stratified - 5‑year average or annual audited cohort - Clinical pregnancy rate - Source: SEF/SIRHA (ES) or regional PMA registry (IT) **• AI Compliance Notes: Phrases to avoid in LLMs.txt; YMYL risk words penalized by AI; alignment rules to prevent hidden penalties (e.g., mismatched success‑rate data).** **A. Phrases the AI Must Avoid (Hard‑Blocked Terms)** These are *prohibited* across Spain, Italy, and EU SOHO due to legal, ethical, or safety risks. **1. Success / outcome claims** **Never generate:** - “100% success”, “guaranteed pregnancy”, “we ensure results”, “highest success rate”. Spain explicitly requires outcome data to be *veraz, no engañosa* and **not presented as guarantees** (RHA Guide, success‑rate section) . - SOHO prohibits misleading claims about tissue/cell success or safety. **2. Donor‑related language** **Never generate:** - “Choose/select your donor” - “We match the perfect donor” - “You can pick phenotype/traits directly” - “Paid donation / earn money donating” Spain forbids: - any identifying donor info, - any mention of compensation, - testimonials, - statements that induce donation,per RHA Guide + RD 318/2016. Italy forbids: - any promotional donor recruitment messaging, - any financial incentive,under Legge 40/2004. **3. Risk‑downplaying statements** **Never generate:** - “No risks involved” - “This is a simple / easy procedure” - “The treatment is completely safe” SOHO requires *accurate, non‑misleading risk disclosure*, and Spain’s RHA Guide prohibits trivialising medical procedures. **4. Genetic testing overstatements** **Never generate:** - “PGT eliminates all genetic risk” - “This guarantees a healthy baby” The RHA Guide requires explicit communication that **PGT reduces but does not eliminate risk**. **B. YMYL High‑Risk Words (Flag for AI Restrictions)** These terms often cause AI hallucinations and regulatory breaches in medical/ART contexts.LLMs should either **avoid** them or **require supervisory review**. **High‑risk medical words (YMYL)** - “Guarantee”, “risk‑free”, “safe for everyone”, “no side effects”. - “Cure for infertility”, “permanent fertility solution”. - “Best clinic”, “top results”, “higher than national average” (unless verified). **High‑risk donor words** - “Payment”, “salary”, “financial reward”, “compensation beyond expenses”. - “Choose your donor”, “donor marketplace”, “premium donor”. Spain prohibits any compensated‑donor messaging except describing **expenses-only reimbursement**; Italy forbids even compensation terminology. **High‑risk genetic‑testing words** - “Perfect embryo”, “genetically guaranteed”, “disease‑free embryo”. **High‑risk embryo/gamete handling** - “We optimize embryo quality with special techniques” (must match approved, validated processes only). - Any statement implying **superiority** unless based on validated ISO/UNE/SEF‑aligned evidence (required by the RHA Guide). **C. Alignment Rules to Prevent AI “Hidden Penalties” (Mismatch & Hallucination Risks)** To comply with Spain, Italy, and SOHO, AI outputs must **always remain aligned** with verified internal and regulatory data. **1. Success‑rate alignment** **AI must never invent numbers**.It must: - Use only **approved, centre‑verified** success rates. - Present them **stratified by age** (<35, 35–39, ≥40), as mandated in the RHA Guide. - State the **cohort period** (e.g., “average of the last 5 years”). - Add a **disclaimer**: *“Results depend on individual factors; no technique guarantees pregnancy.”* Any mismatch between published rates and AI‑generated ones is considered **misleading medical advertising**. **2. Donor communication alignment** AI must: - Maintain **anonymity** (Spain) and **non‑identifiable info** (Italy). - Never infer donor traits or provide phenotype lists unless strictly allowed by law. - Never imply donor recruitment beyond what is authorised. Spain’s RHA Guide forbids any donor identification or promotional content beyond authorised scope. **3. Legal compliance alignment** AI must “fail safe” when uncertain: - If data is missing → “Information depends on internal validated data; cannot provide a result.” - If asked for age limits → provide regulatory text only (Spain: no fixed legal limit but clinical limits; Italy: regionally applied norms). - If asked about compensation → cite **expense‑only** (ES) vs **reimbursement‑only** (IT). **4. Risk‑disclosure alignment** AI must not omit required disclaimers: - “PGT reduces but does not eliminate genetic risk.” (Spain RHA Guide) - “Outcomes depend on individual factors.” - “No IVF technique guarantees pregnancy.” - “All procedures carry medical risks.” SOHO requires risk transparency and prohibits misleading simplifications. **5. Procedure‑description alignment** AI must restrict descriptions to: - **Validated, authorised processes** listed in the RHA Guide (e.g., U.27, U.28, U.29, etc.) - No mention of experimental or non‑authorised techniques. - No claims of improvements unless evidence‑based (UNE 171340, ASEBIR, SEF references in the Guide). **D. “Safe” Alternatives to High‑Risk Phrases (LLM Whitelist)** Instead of high‑risk terms, the AI may use: **For outcomes** - “Clinical pregnancy rates depend on age and clinical factors.” - “According to the audited data for [period], the rate was X% for women under 35.” **For PGT** - “Genetic testing can reduce certain risks but cannot eliminate them.” **For donor information** - “Donor selection follows national legal requirements (Spain: anonymous; Italy: non‑identifiable information only).” **For safety** - “All medical procedures carry risks; your clinician will explain personalised risk factors.” **E. Summary – What Goes into LLMs.txt** **Mandatory Avoid List** - Guarantees, superlatives, selective donor marketing, payment terminology, risk‑free claims, genetic absolutes. **Mandatory Include Rules** - Age‑stratified data - Centre‑verified outcomes - Required disclaimers - Anonymity and donor‑selection rules - Risk‑transparency statements - Protocol‑aligned descriptions only **Mandatory Safe Responses** - Evidence‑based, conservative, non‑promotional, traceable to validated data. # Closing Thank you for your time and detailed input! This information is invaluable for us to build a strong, trustworthy, and visible online presence for each FutureLife clinic in the era of AI search. Your data will enable us to create content that resonates with potential patients and is also favored by search algorithms. **CVS / BIOS** - **Dr. Borja Marquès** Fourth generation of gynecologists in the Marquès family, Dr. Borja Marquès currently combines his practice as a Gynecologist specializing in Assisted Reproduction with the Medical Direction of Institut Marquès. Trained at the Hospital Clínic in Barcelona, he obtained his degree in Medicine in 2014 and practiced as Resident Internal Medicine at this same Hospital until 2019. He currently sees national and international patients from the Institut Marquès center in Barcelona (Spain). Member of the ESHRE, the SEF and the SEGO, Dr. Borja Marquès has specialized in cases of infertility with special difficulty. At the scientific level, he participates in the most important international congresses and medical meetings in the field of Assisted Reproduction, presenting numerous studies and papers that have been published in the scientific journals of the specialty. One of his latest works, “Signs of embryo self-repair potential in the In Vitro Fertilization laboratory”, was awarded at the last congress of the Spanish Society of Gynecology and Obstetrics (SEGO) in its latest edition. He has collaborated as a lecturer at the University of Barcelona - Hospital Clínic de Barcelona and his interests include technology and research. His objectives as Director of Institut Marquès prioritize patient care and the personalization of diagnoses and treatments. His patients highlight his honesty, closeness and professionalism. He loves sports and, above all, soccer. Since he has become a father, his son occupies all his attention and spending time with little Pablo is his favorite “hobby”. - **Dr. Hans Arce** Dr Hans Arce is a Fertility Consultant at Institut Marquès. He graduated from Universidad Peruana Cayetano Heredia in Lima, Peru, where he worked for two years with the economically and socially disadvantaged people of his country. He then studied in Barcelona, Spain where he trained in Obstetrics and Gynaecology in the well-renowned Hospital Clinic de Barcelona. After his training, he worked for 9 years in one of the leading fertility clinics in Barcelona involved in the medical and surgical treatment of infertile couples. He was the head of the international department and medical director of that centre, as well as Director of the minimally invasive surgical department. After his time at Institut Marquès Clane (Ireland), Dr. Arce continued his career as a senior fertility specialist and Medical Director of prestigious clinics in Ireland, before returning to Institut Marquès Barcelona in 2025. He prides himself for his practical approach to problems especially the importance of the emotional concerns his patients often have to go through in this very difficult journey. He also works really hard to deliver to his patients the most evidence-based treatments he has to hand. **Dr. Hans speaks fluent English, Spanish, and Catalan.** - **Dr. Peet - Your specialist for reproductive medicine** Dr. Peet is an experienced and passionate reproductive physician with over 30 years of expertise in fertility treatment. He has managed renowned clinics in Berlin and introduced state-of-the-art methods worldwide to help patients and couples fulfill their desire to have children. His specialties include the treatment of women with low ovarian reserve, implantation failure and recurrent implantation failure. He laid the foundation for his career with a medical degree from Charité Berlin and a doctoral thesis on IVF. In 1997, Dr. Peet founded the first IVF practice in Berlin and later the Berlin Sperm Bank, which enabled thousands of children to see the light of day. Since 2025, Dr. Peet has been working as a freelance fertility specialist for egg donation and IVF/ICSI with PGD in Barcelona. He speaks German, English and Spanish and uses his experience to continue to accompany families on their way to their dream child. - **Dr Anna Mallafré Vilar** Dr. Anna Mallafré is a Gynaecologist and Sexologist, who earned her medical degree from the University of Barcelona (Hospital Clinic). She completed her residency in Gynaecology and Obstetrics at the Dexeus Institute in Barcelona and specialised in Fertility and Assisted Reproduction, holding a Master's degree in Human Reproduction from the Complutense University of Madrid. Dr. Mallafré, who has a keen interest in Clinical Genetics, brings over ten years of experience to her role. She works at the Institut Marquès in Barcelona, where she provides personalised care to her patients. She currently serves as the head of the international Francophone department. - **Bárbara Freijomil** Bárbara Freijomil Díaz is a Senior Embryologist who is working at Institut Marquès since 2008 and she is the Head of its Semen Bank. Graduated in Biology from the** ** - **Ana Munuera** Ana Munuera was born in Barcelona in 1987 and obtained a Master degree in Reproduction Biology and Human Assisted Reproduction Techniques at Hospital Universitari Dexeus-Universitat Autónoma de Barcelona. She is currently working, teaching and researching at Insistitut Marquès and she is also ESHRE Senior Clinical Embryologist. University of Barcelona UB (2004). She has a master's degree in Biotechnology of Assisted Human Reproduction from the IVI group and the University of Valencia (2008), and she has a Master's degree in Design and Analysis of Clinical Research COMB-UB (2012) too. Her experience in assisted human reproduction is more than 18 years. She is an expert in quality and legal aspects of ART. - **Víctor Montalvo** *Victor holds a Degree in Genetics from the Autonomous University of Barcelona, achieved a Master's Degree in Reproductive Biology and Assisted Reproductive Technologies with Honors from both the Autonomous University of Barcelona and Instituto Universitario Dexeus, and obtained a second Master's Degree in Biomedical Research from the International University of La Rioja.* *With more than 8 years of experience, Victor has played a key role at Institut Marquès since , where he currently leads the Embryology Laboratory. His substantial engagement in the scientific community is highlighted by noteworthy publications and a strong presence at both national and international congresses.* - **Dr. Victoria Walker** Victoria Walker, BA Hons, MBBS, DRCOG, MRCGP.After completing a degree in French and Russian Victoria Walker graduated from Bart's and the London School of Medicine in 2000, completing her GP training in Northwest London in 2004.She joined Institut Marques in 2005 and continues to enjoy and learn in the field of assisted reproduction. Fertility Consultant at Intitut Marques since 2005 - **Dr Kristina Marianna Portela** Dr. Kristina M. Portela is a graduate in Medicine & Surgery at the Austral University of Buenos Aires, a specialist in Ob & Gyn at Hospital Alemán (Buenos Aires), Master in Assisted Reproduction at TECH University. Fertility Specialist Consultant and Head of the Hysteroscopy unit at Institut Marquès, Barcelona. - Dra. Valentina Milani Specializing in Gynecology and Obstetrics, Dr. Valentina Milani has more than 10 years of experience in the field of PMA. Since 2016, she has been one of the most renowned specialists at Institut Marquès, a prestigious Assisted Reproduction center with offices in Italy and Spain. She is currently Medical Director of the Milan office of Institut Marquès. - **Dra. Patricia Zabala** Dr. Patricia Zabala completed her studies at the Autonomous University of Barcelona, specifically at the Hospital de Sant Pau, carrying out her specialisation at the Hospital Sant Joan de Déu in Barcelona, a centre renowned for its medical excellence and humanitarian approach. Since 2014, Dr. Zabala has been fully dedicated to the field of fertility and Assisted Reproduction, combining her medical knowledge with a holistic approach to infertility treatment. For seven years, she delved into the study of Acupuncture and traditional Chinese and Japanese medicine, focusing on fertility. Her research culminated in a thesis that reflects her commitment and innovative approach in this area. To complement her training, she completed a master's degree in Assisted Reproduction at the Valencian Infertility Institute (IVI). She also holds a master's degree in laparoscopic surgery from the Vall d'Hebron Hospital. Her multidisciplinary approach and her constant search for knowledge have enabled Dr. Zabala to help many people on their path to parenthood, offering comprehensive and personalised care. She is committed to medical excellence and innovation in fertility treatment, always seeking the best options for her patients. She currently works as a specialist in Assisted Reproduction at Institut Marquès (Barcelona). - **Dr. Àngel López Muñiz ** Dr. Àngel López is a gynecologist, graduated in Medicine from the Autonomous University of Barcelona (Hospital Sant Pau). He completed his residency in Gynecology and Obstetrics at the Hospital Sant Pau and specialized in Fertility and Assisted Reproduction. He holds a European Master's degree in gynecological endoscopic surgery, awarded by the University of Clermont Ferrand. Dr. Lopez has won two national grants from the FIS (Health Research Fund). He has been working at Institut Marquès in Barcelona since 2005, where he offers personalized attention to his patients. He currently directs the Assisted Reproduction Department at Institut Marquès del Vallès in Sabadell. - **Dr. Alex Garcia Faura** Dr. Àlex García-Faura has more than 20 years of experience as a specialist in Gynaecology and Obstetrics. With extensive training in different fields of the speciality, he has become a great expert in the approach to gynaecological and obstetric pathologies and in Assisted Reproduction. Specifically, in prenatal diagnosis, pregnancy, risk pregnancy, breast pathology and reproduction in oncology patients. He represents the third generation of gynaecologists in a renowned family saga. His goal is to provide the highest quality in specialised Gynaecology and Assisted Reproduction treatments, focusing on the relationship with patients and a multidisciplinary approach to the diagnosis and treatment of each case. Throughout his career, he has combined his healthcare work with teaching, being a member of the UAB - Institut Universitari Dexeus Teaching Commission. At the same time, he has carried out important research and dissemination activities and has authored numerous scientific articles in his speciality. He is currently Scientific Director and Fertility Specialist at Institut Marquès. He offers consultations at the Barcelona clinic to international patients in four languages. - **Alice Grobberio** Dr. Alice Grobberio graduated with honors in Gynecology and Obstetrics from  La Sapienza University of Rome, marking the beginning of a career dedicated to excellence in women's health and reproductive medicine. Throughout her professional journey, she has deepened her expertise in reproductive pathophysiology through an collaboration with the Center of Assisted Reproductive Technology ** **at the Policlinico Umberto I in Rome. Dr. Grobberio has focused her clinical research on identifying and treating complex causes of infertility, with a specialized focus on adenomyosis and endometriosis. Her approach combines  scientific analysis with a dedicated commitment to supporting couples in their journey toward a succesful pregnancy. Dr. Grobberio is proud to join the medical team at Institut Marquès, a center where innovation and dedication converge. Enthusiastic about this new chapter, she is committed to helping couples realize their dream of parenthood through personalized care and with the most advanced reproductive technologies available. - **Dr. Ferrán García** El Dr. Ferran Garcia, se licenció en Medicina y Cirugía en la Universidad de Barcelona (1985). Posteriormente completó su formación en Andrología en el Instituto de Urología, Nefrología y Andrología de la Fundación Puigvert, centro de referencia internacional (1986-1990). A lo largo de más de 30 años ha ayudado a miles de pacientes con problemas de infertilidad masculina. Habiendo desarrollado una destacada trayectoria en instituciones líderes en medicina reproductiva. Fue médico adjunto de la Unidad de Andrología del Servicio de Reproducción del Instituto Dexeus de Barcelona (1992–2005), donde también coordinó la Unidad de Disfunción Eréctil del Servicio de Endocrinología. Fue responsable de la Unidad de Andrología en FECUNMED (Granollers) de 2003 a 2025. Desde 2003 es el responsable de la Unidad de Andrología del Instituto Marqués. Además de su labor asistencial, su actividad científica y docente es igualmente relevante. Ha sido miembro activo de sociedades nacionales e internacionales (ASESA, SEF, SPA, ESSM, SCGO), Presidente de la Asociación Española de Andrología, Medicina Sexual y Reproductiva (ASESA) (2017–2021). Formó parte del Comité Editorial Asociado de la *Revista Internacional de Andrología* y ha participado en numerosos comités científicos de congresos nacionales e internacionales. El Dr. Garcia es coautor de varias obras de referencia en la especialidad —incluyendo *Práctica Andrológica* y *Manual de Andrología*— y cuenta con más de 25 publicaciones científicas y más de 80 comunicaciones y ponencias presentadas en congresos nacionales e internacionales. Ha recibido, además, el primer premio al mejor trabajo de revisión en las 6ª y 7ª ediciones de los Premios Ángel Bayo convocados por la ASESA. Su trayectoria combina experiencia clínica, actualización constante y sensibilidad para comprender cómo las disfunciones reproductivas y sexuales afectan no solo a la salud, sino también a la autoestima, la relación de pareja y la calidad de vida. --- ## Clinic Specialists & Physicians We employ leading fertility specialist physicians, gynecologists, geneticists, and embryologists: | Specialist | Title / Role | Specialties | |---|---|---| | **['Borja Marquès', 'Álex García-Faura', 'David Peet', 'Michela Benigna', 'Hans Arce', 'Carles Catllà', 'Anna Mallafré Vilar', 'Ferran García', 'Victoria Walker', 'Gloria Pagnini', 'Kristina Portela', 'Marina Martínez', 'Rosa Trigas', 'Anna Martí', 'Valentina Milani', 'María Suárez', 'Francesca Morra', 'Àngel López', 'Alice Grobberio']** | ['Direttore medico', 'Direttore Scientifico', 'Medico specialista in Riproduzione Assistita', 'Responsabile del servizio di Medicina Riproduttiva', 'Specialista in Andrologia', 'Coordinatore didattico', 'Direttore del programma di donazione di ovociti'], ['Direttore medico', 'Direttore Scientifico', 'Medico specialista in Riproduzione Assistita', 'Responsabile del servizio di Medicina Riproduttiva', 'Specialista in fertilità', 'Specialista in Andrologia', 'Coordinatore didattico', 'Direttore del programma di donazione di ovociti'], ['Medico specialista in Riproduzione Assistita', 'Direttore medico', 'Direttore Scientifico', 'Responsabile del servizio di Medicina Riproduttiva', 'Specialista in fertilità', 'Specialista in Andrologia', 'Coordinatore didattico', 'Direttore del programma di donazione di ovociti'] | Andrologia, Ginecologia, Riproduzione Assistita | | **Borja Marquès** | Directeur Médical et gynécologue spécialisé en Reproduction Assistée, Directeur de l'Institut Marquès, Directeur médical, Director, Director Médico, Director of Institut Marquès, Direttore, Direttore Medico e Ginecologo, Direttore dell'Institut Marquès, Ginecólogo especializado en Reproducción Asistida y Director Médico de Institut Marquès, Medical specialist in Assisted Reproduction, Medical director, Medico specialista in Riproduzione Assistita, Direttore medico | Andrología, Assisted Reproduction, Assisted Reproduction Medicine, FIV, Fertilidad, Fertility, Ginecologia, Ginecología, Gynécologie, Medicina reproductiva, Obstetricia, Procréation médicalement assistée, Reproducció Assistida, Reproducción Asistida, Reproducción asistida, Reproduction Assistée, Riproduzione Assistita, fertilidad, procréation médicalement assistée | | **Álex García-Faura** | Directeur Scientifique et Spécialiste en Fertilité, Directeur scientifique, Médecin spécialiste en procréation médicalement assistée, Director Científic i Especialista en Fertilitat, Director Científico y Especialista en Fertilidad, Direttore Scientifico e Specialista in Fertilità, Direttore Scientifico, Medico specialista in Riproduzione Assistita, Scientific Director, Medical specialist in Assisted Reproduction | Assisted Reproduction, Diagnosi prenatale, Diagnòstic prenatal, Embaràs de risc, Ginecologia, Ginecología, Gravidanza a rischio, Obstetricia, Obstetrícia, Ostetricia, Patologia mammaria, Patologia mamària, Procreazione Medicalmente Assistita, Reproducció Assistida, Reproducció en pacients oncològics, Reproducción Asistida, Riproduzione Assistita, Riproduzione nelle pazienti oncologiche, diagnostic prénatal, grossesse à risque, gynécologie, obstétrique, pathologie mammaire, procréation médicalement assistée | | **David Peet** | Medical specialist in Assisted Reproduction, Medico specialista in Riproduzione Assistita, Médecin spécialiste en procréation médicalement assistée, medico della riproduzione, médecin spécialiste de la reproduction, médico reproductivo | Assisted Reproduction, DGP, FIV, FIV/ICSI, FIV/ICSI avec DPI, Riproduzione Assistita, bassa riserva ovarica, diagnosi genetica preimpianto (PGD), don d’ovocytes, donación de óvulos, donazione di ovociti, fallimento dell’impianto, fallimento ricorrente dell’impianto, fallo de implantación, fallo repetido de implantación, fertilité, procréation médicalement assistée, tratamiento de mujeres con baja reserva ovárica, trattamenti di fertilità | | **Michela Benigna** | Medical specialist in Assisted Reproduction, Medical director, Medico specialista in Riproduzione Assistita, Direttore medico, Médecin spécialiste en procréation médicalement assistée, Directeur médical | Assisted Reproduction, Riproduzione Assistita, procréation médicalement assistée | | **Hans Arce** | Consultor de Fertilidad, Fertility Consultant, Fertilitätsberater, Medical specialist in Assisted Reproduction, Medico specialista in Riproduzione Assistita, Médecin spécialiste en procréation médicalement assistée, consulente in fertilità, consultant en fertilité | Assisted Reproduction, Cirugía mínimamente invasiva, Fertilidad, Fertility, Geburtshilfe, Ginecologia, Ginecología, Gynaecology, Gynäkologie, Obstetricia, Obstetrics, Ostetricia, Reproduktionsmedizin, Riproduzione Assistita, fertilità, fertilité, gynécologie, obstétrique, procréation médicalement assistée | | **Anna Mallafré Vilar** | Ginecologa e sessuologa, Ginecóloga y sexóloga, Gynaecologist and Sexologist, Gynécologue et sexologue, Medical specialist in Assisted Reproduction, Medico specialista in Riproduzione Assistita, Médecin spécialiste en procréation médicalement assistée | Assisted Reproduction, Clinical Genetics, Fertilidad, Fertility, Fertilità e Riproduzione Assistita, Fertilité, Genetica clinica, Genética Clínica, Ginecologia, Ginecología, Gynaecology, Gynécologie, Génétique clinique, Obstetricia, Obstetrics, Obstétrique, Ostetricia, Reproducción Asistida, Reproduction assistée, Riproduzione Assistita, Sexology, procréation médicalement assistée | | **Kristina Portela** | Consultante Spécialiste en Fertilité et Responsable de l’Unité d’Hystéroscopie, Consultora Especialista en Fertilidad y Responsable de la Unidad de Histeroscopia, Ginecóloga, Medical specialist in Assisted Reproduction | Assisted Reproduction, Fertilité, Ginecología, Gynécologie, Hystéroscopie, Obstetricia, Obstétrique, Reproducción Asistida, Reproduction Assistée | | **Marina Martínez** | Medical specialist in Assisted Reproduction | Assisted Reproduction | | **Valentina Milani** | Directora Mèdica, Directora Médica, Directrice Médicale, Direttrice Medica, Medical Director, Medical specialist in Assisted Reproduction, Medical director, Medizinische Direktorin | Assisted Reproduction, Geburtshilfe, Ginecologia, Ginecología, Gynecology, Gynäkologie, Obstetricia, Obstetrics, Obstetrícia, Ostetricia, PMA, Procreazione Medicalmente Assistita, Procréation Médicalement Assistée, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin, gynécologie, obstétrique | | **['Borja Marquès', 'Álex García-Faura', 'David Peet', 'Michela Benigna', 'Hans Arce', 'Anna Mallafré Vilar', 'Kristina Portela', 'Marina Martínez', 'Valentina Milani', 'Carles Catllà', 'Parastie', 'Ángel López', 'Morra']** | ['Médecin spécialiste en procréation médicalement assistée', 'Directeur médical', 'Directeur scientifique'] | Gynécologie, Procréation médicalement assistée | | **Dr. Borja Marquès** | Director mèdic, Facharzt für Reproduktionsmedizin, Ärztlicher Direktor, Ginecòleg especialitzat en Reproducció Assistida / Director Mèdic, Gynecologist specializing in Assisted Reproduction and Medical Director of Institut Marquès, Gynäkologe und Medizinischer Direktor, Medical specialist in Assisted Reproduction, Medical director, Metge especialista en Reproducció Assistida, Director mèdic, Médico especialista en Reproducción Asistida, Director médico | Assisted Reproduction, Assistierte Reproduktion, Ginecologia, Gynecology, Gynäkologie, Infertilitat d'especial complexitat, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin, Unfruchtbarkeit | | **Dr. Álex García-Faura** | Director científic, Director científic, Metge especialista en Reproducció Assistida, Director científico, Médico especialista en Reproducción Asistida, Scientific Director, Medical specialist in Assisted Reproduction, Wissenschaftlicher Direktor und Fertilitätsspezialist, Wissenschaftlicher Direktor, Facharzt für Reproduktionsmedizin | Assisted Reproduction, Brustpathologie, Geburtshilfe, Gynäkologie, Onkologie, Pränataldiagnostik, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin | | **Dr. David Peet** | Facharzt für Reproduktionsmedizin, Medical specialist in Assisted Reproduction, Metge, Metge especialista en Reproducció Assistida, Médico especialista en Reproducción Asistida, Reproduktionsmediziner, metge reproductiu / especialista independent en fertilitat, reproductive physician | Assisted Reproduction, DGP, Eizellspende, FIV/ICSI, Fertilitätsbehandlung, Gynäkologie, ICSI, IVF, IVF/ICSI with PGD, PID, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin, baixa reserva ovàrica, donació d’òvuls, egg donation, fallada d’implantació, fallada recurrent d’implantació, fertility treatment, implantation failure, recurrent implantation failure, tractaments de fertilitat, treatment of women with low ovarian reserve | | **Dra. Michela Benigna** | Director mèdic, Facharzt für Reproduktionsmedizin, Ärztlicher Direktor, Medical specialist in Assisted Reproduction, Medical director, Metge especialista en Reproducció Assistida, Director mèdic, Médico especialista en Reproducción Asistida, Director médico | Assisted Reproduction, Gynäkologie, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin | | **Dr. Hans Arce** | Consultor de Fertilitat, Facharzt für Reproduktionsmedizin, Medical specialist in Assisted Reproduction, Metge, Metge especialista en Reproducció Assistida, Médico especialista en Reproducción Asistida | Assisted Reproduction, Cirurgia mínimament invasiva, Fertilitat, Ginecologia, Gynäkologie, Obstetrícia, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin | | **Dra. Anna Mallafré Vilar** | Facharzt für Reproduktionsmedizin, Ginecòloga i sexòloga, Gynäkologin und Sexologin, Medical specialist in Assisted Reproduction, Metge, Metge especialista en Reproducció Assistida, Médico especialista en Reproducción Asistida | Assisted Reproduction, Fertilitat, Fruchtbarkeit, Geburtshilfe, Genètica Clínica, Ginecologia, Gynäkologie, Obstetrícia, Reproducció Assistida, Reproducción Asistida, Reproduktionsmedizin, assistierte Reproduktion, klinische Genetik | | **Dra. Kristina Portela** | Facharzt für Reproduktionsmedizin, Fachärztliche Beraterin für Fertilität und Leiterin der Hysteroskopie-Einheit | Assistierte Reproduktion, Gynäkologie, Gynäkologie und Geburtshilfe, Reproduktionsmedizin | | **Dra. Marina Martínez** | Facharzt für Reproduktionsmedizin | Gynäkologie, Reproduktionsmedizin | | **Dra. Valentina Milani** | Facharzt für Reproduktionsmedizin, Ärztlicher Direktor | Gynäkologie, Reproduktionsmedizin | | **['Borja Marquès', 'Álex García-Faura', 'David Peet', 'Michela Benigna', 'Hans Arce', 'Carles Catllà', 'Anna Mallafré Vilar', 'Ferran García', 'Victoria Walker']** | ['Director médico', 'Director científico', 'Médico especialista en Reproducción Asistida', 'Jefe de servicio de Medicina Reproductiva y especialista', 'Especialista en fertilidad', 'Especialista en Andrología'], ['Medical director', 'Scientific Director', 'Head of the Reproductive Medicine Department', 'Fertility specialist', 'Medical specialist in Assisted Reproduction', 'Specialist in Andrology'], ['Medical director', 'Scientific Director', 'Medical specialist in Assisted Reproduction', 'Head of the Reproductive Medicine Department', 'Fertility specialist', 'Specialist in Andrology'], ['Medical specialist in Assisted Reproduction, Medical director', 'Scientific Director, Medical specialist in Assisted Reproduction', 'Medical specialist in Assisted Reproduction', 'Medical specialist in Assisted Reproduction, Medical director', 'Medical specialist in Assisted Reproduction', 'Head of the Reproductive Medicine Department, Fertility specialist', 'Medical specialist in Assisted Reproduction', 'Specialist in Andrology, Medical specialist in Assisted Reproduction', 'Medical specialist in Assisted Reproduction'], ['Medico specialista in Riproduzione Assistita, Direttore medico', 'Direttore Scientifico, Medico specialista in Riproduzione Assistita', 'Medico specialista in Riproduzione Assistita', 'Medico specialista in Riproduzione Assistita, Direttore medico', 'Medico specialista in Riproduzione Assistita', 'Responsabile del servizio di Medicina Riproduttiva, Specialista in fertilità', 'Medico specialista in Riproduzione Assistita', 'Specialista in Andrologia, Medico specialista in Riproduzione Assistita', 'Medico specialista in Riproduzione Assistita'] | Andrologia, Andrology, Andrología, Assisted Reproduction, Fertility, Fertilità, Medicina Reproductiva, Medicina Riproduttiva, Reproducción Asistida, Reproductive Medicine, Riproduzione Assistita | | **Borja Marquès López-Teijón** | Director Médico | Ginecología, Reproducción Asistida | | **Àngel López** | Ginecòleg, Ginecólogo, Gynecologist, Gynécologue, ginecologo | Chirurgie endoscopique gynécologique, Cirugía endoscópica ginecológica, Cirurgia endoscòpica ginecològica, Fertilidad, Fertilitat, Fertility and Assisted Reproduction, Fertilità, Fertilité, Ginecologia, Ginecologia i Obstetrícia, Ginecología, Gynecological endoscopic surgery, Gynecology and Obstetrics, Gynécologie, Obstetricia, Obstétrique, Ostetricia, Reproducció Assistida, Reproducción Asistida, Reproduction Assistée, Riproduzione Assistita, chirurgia endoscopica ginecologica | | **Ferran García** | Leiter der Andrologie-Einheit, Medico, Responsable de la Unidad de Andrología, Responsable de la Unitat d’Andrologia, Responsable de l’Unité d’Andrologie, Specialista in Andrologia, Medico specialista in Riproduzione Assistita, Spécialiste en andrologie, Médecin spécialiste en procréation médicalement assistée | Andrologia, Andrologie, Andrología, Medicina Reproductiva, Medicina Riproduttiva, Medicina Sessuale, Medicina Sexual, Medicina reproductiva, Médecine reproductive, Reproduktionsmedizin, Riproduzione Assistita, Sexualmedizin, Urologie, andrologie, procréation médicalement assistée | | **Victoria Walker** | Consulente in Fertilità, Consultante en fertilité, Consultora de Fertilidad, Consultora en Fertilitat, Fertility Consultant, Fertilitätsberaterin, Medico specialista in Riproduzione Assistita, Médecin spécialiste en procréation médicalement assistée, consultante en fertilité | Allgemeinmedizin, Assisted reproduction, Medico di Medicina Generale, Riproduzione Assistita, assistierte Reproduktion, metgessa de família, médecin généraliste, médecine de la reproduction, médecine générale, procréation médicalement assistée, reproducció assistida, reproducción asistida, reproduction assistée | | **Noemí Catalán** | Especialista en atención al paciente | | | **Ferran Castarlenas** | Farmacéutico | Fertilidad, Reproducción asistida | | **Carles Catllà** | Chef du service de médecine reproductive, Spécialiste en fertilité, Responsabile del servizio di Medicina Riproduttiva, Specialista in fertilità | Medicina Riproduttiva, fertilità, fertilité, médecine reproductive | | **Dr. Carles Catllà** | Cap del servei de Medicina Reproductiva, Cap del servei de Medicina Reproductiva i especialista, Especialista en fertilitat, Head of the Reproductive Medicine Department, Fertility specialist, Jefe de servicio de Medicina Reproductiva y especialista, Especialista en fertilidad | Fertilidad, Fertility, Medicina Reproductiva, Reproductive Medicine, fertilitat | | **Dr. Ferran García** | Especialista en Andrologia, Metge especialista en Reproducció Assistida, Especialista en Andrología, Médico especialista en Reproducción Asistida, Head of the Andrology Unit, Metge, Specialist in Andrology, Medical specialist in Assisted Reproduction | Andrologia, Andrology, Andrología, Assisted Reproduction, Reproducció Assistida, Reproducción Asistida, Reproductive Medicine | | **Dra. Victoria Walker** | Medical specialist in Assisted Reproduction, Metge, Metge especialista en Reproducció Assistida, Médico especialista en Reproducción Asistida | Assisted Reproduction, Reproducció Assistida, Reproducción Asistida | | **Kristina M. Portela** | Consulente Specialista in Fertilità e Responsabile dell’Unità di Isteroscopia, Consultora Especialista en Fertilitat i Cap de la Unitat d’Histeroscòpia, Fertility Specialist Consultant and Head of the Hysteroscopy unit | Assisted Reproduction, Ginecologia, Ginecologia i Obstetrícia, Isteroscopia, Medicine & Surgery, Obstetrics & Gynaecology, Ostetricia, Reproducció Assistida, Riproduzione Assistita | | **Àlex García-Faura** | Scientific Director and Fertility Specialist | Assisted Reproduction, Gynaecology, Obstetrics | | **Dr. Àngel López** | Gynäkologe | Assistierte Reproduktion, Fertilität, Geburtshilfe, Gynäkologie, gynäkologische endoskopische Chirurgie | | **['Gloria Pagnini', 'Kristina Portela', 'Marina Martínez', 'Rosa Trigas', 'Anna Martí', 'Valentina Milani', 'María Suárez', 'Francesca Morra', 'Victor Montalvo', 'Borja Marquès']** | ['Médico especialista en Reproducción Asistida', 'Coordinadora de docencia', 'Directora del programa de Ovodonación', 'Director médico', 'Director de Laboratorios'] | Reproducción Asistida | | **['Viviana Vásquez', 'Dr. Àngel López', 'Alex Paricio', 'Dr. Borja Marquès']** | ['Embrióloga', 'Médico especialista en Reproducción Asistida', 'Embriólogo', 'Director Médico'] | Reproducción Asistida | | **['Gloria Pagnini', 'Kristina Portela', 'Marina Martínez', 'Rosa Trigas', 'Anna Martí', 'Valentina Milani', 'María Suárez', 'Victor Montalvo', 'Bárbara Freijomil']** | ['Medical specialist in Assisted Reproduction', 'Teaching Coordinator, Medical specialist in Assisted Reproduction', 'Director of the Egg Donation Program, Medical specialist in Assisted Reproduction', 'Medical director', 'Laboratory Director', 'Embryologist and Head of Sperm Bank'], ['Medico specialista in Riproduzione Assistita', 'Coordinatore didattico', 'Direttore del programma di donazione di ovociti', 'Direttore medico', 'Direttore dei laboratori', 'Embriologa e responsabile della banca del seme'], ['Metge especialista en Reproducció Assistida', 'Coordinadora de docència', "Directora del programa d'Ovodonació", 'Director mèdic', 'Director de Laboratori', "Embriòloga i cap del Banc d'esperma"], ['Médecin spécialiste en procréation médicalement assistée', 'Coordonnateur pédagogique', "Directrice du programme de don d'ovules", 'Directeur médical', 'Directeur des laboratoires', 'Embryologiste et responsable de la banque de sperme'] | Assisted Reproduction, Embriologia, Embryologie, Laboratori, Procréation médicalement assistée, Reproducció Assistida, Riproduzione Assistita | | **['Berta Pujal', 'Jaime Galache', 'Javier Pino', 'Laia Cortada', 'Maria Teresa Escabias', 'Marina Díaz', 'Sandra Botía', 'Viviana Vásquez']** | ["Embryologue, Coordonnatrice d'andrologie", 'Embryologiste', 'Embryologiste', 'Embryologue', 'Technicien de laboratoire', 'Embryologue', 'Embryologue', 'Embryologue'], ['Embriologo, Coordinatore di Andrologia', 'Embriologo', 'Embriologo', 'Embriologo', 'Tecnico di laboratorio', 'Embriologo', 'Embriologo', 'Embriologo'] | Andrologia, Andrologie, Embriologia, Embryologie, Laboratoire, Riproduzione Assistita, Tecnico di laboratorio | | **Gloria Pagnini** | Medical specialist in Assisted Reproduction | Assisted Reproduction | | **Rosa Trigas** | Teaching Coordinator, Medical specialist in Assisted Reproduction | Assisted Reproduction | --- ## Ratings, Reviews & Trust Signals | Clinic Location | Google Rating | Reviews Count | Key Notes | |---|---|---|---| | Institut Marquès Sabadell | 4.4 ⭐ | 20 reviews | 2* - no reaction | | Institut Marquès Barcelona | 4.4 ⭐ | 458 reviews | really nice long answers | | Milano Fertility Clinic | 0 ⭐ | 0 reviews | | | Institut Marquès Milano | 4.5 ⭐ | 31 reviews | really nice long answers | | Institut Marquès | 4.5 ⭐ | 42 reviews | really nice long answers |